Article Name Predictive Diagnostics
This is the second genomics facility to be operated by Redcliffe Labs in India
22nd October, 2023
GE HealthCare a collaboration with Novo Nordisk to further advance the clinical and product development of peripheral focused ultrasound (PFUS). This is a novel technology that has potential to specifically regulate metabolic function in the body using ultrasound that may support the treatment of chronic diseases such as type 2 diabetes and obesity.
20th October, 2023
SHL Medical ("SHL"), a world-leading solutions provider of advanced drug delivery systems such as autoinjectors and innovative specialty delivery systems, has entered into a non-exclusive co-marketing partnership agreement with Lifecore Biomedical (Nasdaq: LFCR) ("Lifecore"), a fully integrated Contract Development and Manufacturing Organization ("CDMO") that offers highly differentiated capabilities in the development, fill and finish of complex sterile injectable pharmaceutical products in syringes and vials.
19th October, 2023
Healthcare localization and standardization support the Belt and Road Initiative
19th October, 2023
GE HealthCare (Nasdaq: GEHC) announced US FDA 510(k) clearance of Allia IGS Pulse - the latest addition to the company’s image guided system (IGS) offerings. Allia IGS Pulse features a new imaging chain engineered to provide exceptional imaging at the right dose for visible impact in complex cardiology interventions regardless of patient size.
17th October, 2023
Sensor can potentially provide an easy, low-cost alternative to expensive footwear modifications
17th October, 2023
On the occasion of World Anaesthesia Day, MedTech Spectrum & BioSpectrum India delve into the dynamic world of healthcare and technological innovation. We had the privilege of speaking with Mr. Shalin Patel, the Managing Director of Draeger India Group, a prominent player in the medical and safety technology sector.
16th October, 2023
Nearly 50% of American adults living with diabetes will be affected by diabetic neuropathy complications in their lifetime
14th October, 2023
Roche announced new data from the Phase II FENopta study showing that investigational, oral fenebrutinib is brain penetrant and reduces brain lesions in people with relapsing multiple sclerosis (RMS) with a consistent safety profile to other fenebrutinib trials. The late-breaking data were featured in an oral presentation at the 9th Joint ECTRIMS-ACTRIMS Meeting (European and Americas Committees for Treatment and Research in Multiple Sclerosis).
14th October, 2023
FirstLook Lung uses a breakthrough technology of whole-genome machine learning to analyze fragments of cell-free DNA that are markers of cancer in the blood
11th October, 2023
New roles and additional footprint expansion to support global growth
09th October, 2023
Newborn screening is a critical public health program involving the testing of newborn infants for specific genetic, metabolic, and congenital disorders shortly after birth
29th September, 2023
Fujitsu Limited and iSurgery Co., Ltd. announced that they will conduct a field trial as part of their “bone health promotion project” from October 2023 to March 2025 in collaboration with the Department of Orthopaedic Surgery at the Jikei University School of Medicine (1), to verify the practicality of bone assessments (2) conducted with chest radiographs and the effects of this approach in changing Fujitsu employees’ attitudes and habits around health. This marks the first time in Japan that an employer is focusing on the improvement of this aspect of its employees’ health during their examinations through this novel use of chest radiographs for bone assessments.
26th September, 2023
Partnership acknowledges the increasing mental health challenges faced by students
25th September, 2023
Blood-based protein biomarkers have emerged as a promising tool for the early detection of Alzheimer's disease
11th September, 2023
Medical humanities education expanded to train future-ready doctors to be agile
11th September, 2023
Acquisition will bring together two leaders in different aspects of diabetes care
07th September, 2023
IVIS® Spectrum 2 and IVIS SpectrumCT 2imaging systems — new flagship platforms setting the standard in high-throughput performance and versatility
06th September, 2023
© 2023 MM Activ Sci-Tech Communications. All rights reserved | Disclaimer